EPO approves Pharmistas patent application

The EPO has approved Pharmistas European patent application for “A REUSABLE TEST DEVICE” following our successful PCT application.

The recognition from the EPO signifies a breakthrough achievement in the field of reusable in vitro diagnostics and underscores the novelty of Pharmista’s reusable platform technology.

Previous
Previous

Alice participates in Dagens Industris competition Female Founders

Next
Next

Pharmista presents at TechBBQ